Abbott Nutrition, a leading baby formula company, is facing scrutiny for co-sponsoring a national paediatrics summit in Dehradun, India. This move has raised concerns as it goes against laws that prohibit baby food manufacturers from funding medical conferences. The Indian Academy of Paediatrics had previously accepted funding from Abbott, arguing that it was from a separate division of the company. However, the health ministry has flagged this as a violation of the Infant Milk Substitutes Act. The summit, which is set to bring together paediatricians from across the country, has sparked a debate on the ethics of accepting sponsorship from companies that produce baby food products. This controversy highlights the delicate balance between promoting infant health and avoiding conflicts of interest in the medical field. The issue has reignited discussions on the regulations surrounding the marketing and promotion of baby formula in India. As the summit approaches, stakeholders are closely monitoring the situation to ensure that ethical standards are upheld in the medical community.